$ERAS
Erasca, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$14.72
▼-0.14%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateErasca, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ERAS down today? It is at $14.72 (-0.14%), and our scanner flagged it 131 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ERAS spikes, and full due diligence on ERAS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ERAS 131 times in the last 30 days. Create a free account to track $ERAS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ERAS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ERAS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing144Notice of proposed insider sale (144)Sep 15, 2026 · 20 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
4,714,285 new shares · Priced at $17.5/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Garner Ebun Officer | Sold (automatic/other) | -80K 0.02% of company | sold 76% | 25K | $1.3M at $16.40 | Apr 1, 26 |
Garner Ebun Officer | Other | 80K 0.02% of company | added 100% | 105K | $136K at $1.70 | Apr 1, 26 |
Morris Shannon Officer | Sold (automatic/other) | -20K | n/a | n/a | $301K at $15.04 | Mar 4, 26 |
Morris Shannon Officer | Other | 20K | n/a | 20K | $34K at $1.70 | Mar 4, 26 |
Garner Ebun Officer | Sold (automatic/other) | -120K 0.03% of company | sold 83% | 25K | $671K at $5.59 | Jan 7, 26 |
Garner Ebun Officer | Other | 120K 0.03% of company | added 100% | 145K | $204K at $1.70 | Jan 7, 26 |
Garner Ebun Officer | Acquired (grant/award) | +4K | added 18% | 25K | $5K at $1.19 | Dec 15, 25 |
Chacko David M. Officer | Acquired (grant/award) | +18K | added 6.8% | 280K | $21K at $1.19 | Dec 15, 25 |
Multani Pratik S Director | Sold (automatic/other) | -6K | sold 3.6% | 167K | n/a | May 23, 25 |
Multani Pratik S Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | May 23, 25 |
Garner Ebun Officer | Acquired (grant/award) | +6K | added 37% | 21K | $9K at $1.56 | Dec 13, 24 |
Chacko David M. Officer | Acquired (grant/award) | +12K | added 4.9% | 262K | $19K at $1.56 | Dec 13, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ERAS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ERAS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ERAS last traded at $14.72, down 0.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Erasca, Inc. Common Stock (ERAS) is next expected to report earnings on Wednesday, November 11, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ERAS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ERAS 131 times in the last 30 days.
ERAS (Erasca, Inc. Common Stock) trades on XNAS, with a market cap of about $5.15B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ERAS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ERAS discussion
Sign in to ask a question or join the discussion.